Blis Technologies Faces Financial Setback Amid Trade Secret Breach

Blis Technologies Limited (NZX: BLT), a New Zealand-based producer of probiotic strains, is bracing for a financial impact due to an alleged breach of trade secrets. The company has accused a European manufacturer and a key customer of using its confidential information in patent filings for fermentation processes in the US, Europe, and China. The patent application reportedly discloses Blis’ proprietary trade secrets, leading to significant financial implications for the company. Blis is taking legal action to address this breach and recover potential losses, as the disclosure could affect its competitive advantage in the global market.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com